Compounded medications require the same clinical vigilance as branded options, and no platform should serve as a substitute for regular medical oversight
Tirzepatide outperforms semaglutide in real-world data: higher adherence, weight loss, and cost-effectiveness Fascinating real-world data confirming what many suspected from trials like SURPASS-2: tirzepatide consistently outperforms semaglutide in both glycemic control and weight reduction, even among GLP1 experienced patients
Serious liver injury can develop before a person feels alarmed
Now, a US-wide trial will test whether tirzepatide, the active ingredient in Zepbound, may be an effective treatment for people with long Covid
GLP-1s are smarterthey act when needed
Have you, or someone you know, been affected by this change in TRICARE For Life coverage